Alternatives to weekly injections of weight-loss drugs may be on the way. A monthly dose of a new drug called MariTide helped participants in a phase 2 clinical trial shed about 20% of their body ...

Bradner said weight loss has been comparable to monthly doses, but more side effects have been reported. The next step for Amgen will be a phase 3 trial, which will run for 72 weeks.

Bradner said weight loss has been comparable to monthly doses, but more side effects have been reported. The next step for Amgen will be a phase 3 trial, which will run for 72 weeks.

Dr. Jeffrey Kopin, Chief Medical Officer for Northwestern Medicine Lake Forest Hospital, joins John Williams to talk about the hot weather and what you need to know to protect yourself, the new ‘razor ...

A new trial has found that a weight loss drug taken monthly helps people to lose 20 percent of their body weight.. Other weight loss medications such as Ozempic, Wegovy and Mounjaro have become ...

The treatment led to an average 20 per cent weight loss in people living with obesity alone and a nearly 17 per cent mean weight loss in those living with obesity and type 2 diabetes, the study found.

A new trial has found that a weight loss drug taken monthly helps people to lose 20 percent of their body weight.. Other weight loss medications such as Ozempic, Wegovy and Mounjaro have become ...

Eli Lilly, Novo Nordisk and Amgen release weight loss drug data as competition heats up in the market, while Abridge announces a $300 million funding round.